Department of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University 60800, Multan, Pakistan.
Department of Pharmacy, The Women University, Multan, Pakistan.
J Physiol Pharmacol. 2020 Aug;71(4). doi: 10.26402/jpp.2020.4.10. Epub 2020 Dec 12.
The lithium-pilocarpine model in rats is commonly used to study the characteristic events of acute status epilepticus (SE), epileptogenesis and temporal lobe epilepsy (TLE). Here we investigated the impact of lacosamide alone and in combination with other drugs (pregabalin, piracetam and scopolamine) on spontaneous recurrent seizures (SRSs) and behavioral parameters during the time frame of 6 weeks after SE. In addition, the level of oxidative stress in the hippocampus was accessed by real-time microdialysis study (8-isoprostanes) and antioxidants enzymes in the homogenate. Results revealed severe behavioral deficits with the control epileptic group and animals displayed hyperexcitability, aggression apprehension and memory insufficiency. Pharmacological manipulation for 6 weeks with lacosamide (L) - 80 mg/kg; in polypharmacy with pregabalin (L/P) - 50/50 mg/kg and piracetam (L/Pi) - 50/140 mg/kg significantly (P < 0.05) ameliorated the anxiety-related behavior (open filed, elevated plus maze, light/dark tests), depression (forced swim test) and improved spatial/reference memory (Morris water maze). There were low incidences of seizures in L, L/P and L/Pi groups revealing disease-modifying effects of employed drugs. Furthermore, the chronic use of scopolamine (L/P/S; 50/50/2 mg/kg) as polypharmacy with the concept of antagonizing the cholinergic inputs in the epileptogenic phase aberrated the behavioral situation further worse. Treatments with L/P and L/Pi significantly attenuated (P < 0.05) the oxidative stress by reducing 8-isoprostanes and malondialdehyde (MDA) levels. Furthermore, superoxide dismutase (SOD) and glutathione peroxidase (GPx) levels in the L/P group were significantly (P < 0.05) improved. Overall, our findings support the use of a combination of drugs (L/P and L/Pi) in lithium-pilocarpine model which remarkably ameliorated SRSs, reduced anxiety-related behaviors, retention of spatial/reference memory and lowered oxidative stress in a time-course evaluation 6 weeks post- SE insult.
锂-匹罗卡品大鼠模型常用于研究急性癫痫持续状态(SE)、癫痫发生和颞叶癫痫(TLE)的特征事件。在这里,我们研究了左乙拉西坦单独使用以及与其他药物(普瑞巴林、吡拉西坦和东莨菪碱)联合使用对 SE 后 6 周内自发性复发发作(SRS)和行为参数的影响。此外,通过实时微透析研究(8-异前列腺素)和匀浆中的抗氧化酶来评估海马体中的氧化应激水平。结果显示,对照组癫痫动物表现出严重的行为缺陷,表现出过度兴奋、攻击性恐惧和记忆不足。用左乙拉西坦(L)-80mg/kg;联合用药(L/P)-50/50mg/kg 和吡拉西坦(L/Pi)-50/140mg/kg 进行 6 周的药物处理显著(P<0.05)改善了焦虑相关行为(旷场、高架十字迷宫、明暗测试)、抑郁(强迫游泳试验)和空间/参考记忆(莫里斯水迷宫)。L、L/P 和 L/Pi 组的癫痫发作发生率较低,表明所使用药物具有疾病修饰作用。此外,慢性使用东莨菪碱(L/P/S;50/50/2mg/kg)作为联合用药,概念上拮抗癫痫形成阶段的胆碱能输入,进一步恶化了行为情况。L/P 和 L/Pi 的治疗显著(P<0.05)降低了 8-异前列腺素和丙二醛(MDA)水平,从而减轻了氧化应激。此外,L/P 组的超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)水平显著(P<0.05)改善。总的来说,我们的研究结果支持在锂-匹罗卡品模型中使用药物联合治疗(L/P 和 L/Pi),这可以显著改善 SRS,减少焦虑相关行为,保持空间/参考记忆,并在 SE 后 6 周的时间过程评估中降低氧化应激。